INTS Intensity Therapeutics, Inc. - Common Stock
$4,31
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$0–$8
52% of range
Analystenbewertung
BUY
11 analysts
Kursziel
$25
+475% upside
P/E (TTM)
-0.5
ROE
-165.1%
Nettogewinnmarge
—
INTS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.31
Marktkapitalisierung
$11M
P/E (TTM)
-0.5
EPS (TTM)
$-8.56
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-165.1%
Verschuldungsgrad
—
52W-Spanne
$0 – $8
INTS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-8.56
2022-12-31
→
2025-12-31
Freier Cashflow
—
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
INTS
Peer-Median
P/E (TTM)
-0.5
—
P/B (K/B)
0.9
1.8
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
INTS
Peer-Median
ROA
-122.9%
-102.4%
ROE
-165.1%
-82.4%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
INTS
Peer-Median
Current Ratio (Liquiditätsgrad)
5.9
5.9
Quick Ratio
5.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
INTS
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
INTS
Peer-Median
INTS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
11 Analysten
- Starker Kauf 2 18,2%
- Kauf 8 72,7%
- Halten 1 9,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
5 Analysten · 2026-08-14
Median
$30.00
Mittelwert
$24.80
← Unter allen Zielen
$4.31
Tief
$12.00
Hoch
$32.00
Median-Ziel
$30.00
+595,8%
Mittelwert-Ziel
$24.80
+475,2%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.39%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.96 | $-1.11 | 0.15% |
| 31. Dezember 2025 | $-1.31 | $-1.27 | -0.04% |
| 30. September 2025 | $-1.50 | $-2.23 | 0.73% |
| 30. Juni 2025 | $-3.25 | $-5.04 | 1.8% |
| 31. März 2025 | $-5.50 | $-4.97 | -0.53% |
| 31. Dezember 2024 | $-5.50 | $-5.71 | 0.21% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| INTS | $1M | -0.0 | — | — | -165.1% | — |
| AIXC | — | -0.3 | — | — | — | — |
| GTBP | $20M | -0.1 | — | — | -645.4% | — |
| PDSB | — | -1.0 | — | — | — | — |
| PHIO | $12M | -0.2 | — | — | -57.5% | — |
| INAB | $23M | -0.5 | — | — | -90.8% | — |
| OSRH | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $7M | $10M | $5M | $5M | |
| SG&A Expense | $5M | $6M | $4M | $2M | |
| Operating Expenses | $12M | $17M | $8M | $8M | |
| Operating Income | $-12M | $-17M | $-8M | $-8M | |
| Interest Expense | · | · | $305.0K | $82.0K | |
| Interest Income | $180.0K | $314.0K | $324.0K | $2.0K | |
| Other Non-op | $186.0K | $3.0K | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-12M | $-16M | $-11M | $-8M | |
| EPS (Basic) | $-8.56 | $-29.24 | $-1.38 | $-2.22 | |
| EPS (Diluted) | $-8.56 | $-29.24 | $-1.38 | $-2.22 | |
| Shares (Basic) | 1,356,358 | 556,279 | 8,616,324 | 3,410,103 | |
| Shares (Diluted) | 1,356,358 | 556,279 | 8,616,324 | 3,410,103 | |
| EBITDA | $-12M | $-17M | $-8M | · |
Bilanz 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $3M | $9M | $1M | |
| Prepaid Expense | $788.0K | $773.0K | $688.0K | $63.0K | |
| Other Current Assets | · | · | $6.0K | $76.0K | |
| Current Assets | $13M | $3M | $15M | $1M | |
| Other Non-current Assets | $1M | $1M | $2M | $167.0K | |
| Total Assets | $14M | $5M | $17M | $2M | |
| Accounts Payable | $583.0K | $1M | $3M | $603.0K | |
| Accrued Liabilities | $2M | $508.0K | $891.0K | $2M | |
| Current Liabilities | $2M | $2M | $4M | $7M | |
| Capital Leases | $79.0K | $110.0K | $138.0K | $0 | |
| Other Non-current Liabilities | · | $0 | $36.0K | $36.0K | |
| Total Liabilities | $2M | $2M | $4M | $7M | |
| Common Stock | $0 | $0 | $1.0K | $0 | |
| Paid-in Capital | $90M | $70M | $64M | $24M | |
| Retained Earnings | $-78M | $-67M | $-51M | $-39M | |
| Stockholders' Equity | $12M | $3M | $13M | $-15M | |
| Liabilities + Equity | $14M | $5M | $17M | $2M | |
| Shares Outstanding | 2,524,475 | 604,915 | 13,709,377 | 3,410,103 |
Cashflow 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $2M | $3M | $1M | $1M | |
| Operating Cash Flow | $-9M | $-15M | $-7M | $-5M | |
| Investing Cash Flow | $0 | $6M | $-6M | $0 | |
| Debt Issued | · | $0 | $230.0K | $2M | |
| Net Debt Issued | · | $0 | $230.0K | · | |
| Financing Cash Flow | $19M | $3M | $20M | $2M | |
| Net Change in Cash | $9M | $-6M | $7M | $-3M |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -122.9% | -147.4% | -110.6% | · | |
| ROE | -165.1% | -571.1% | -72.5% | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 5.9 | 1.9 | 3.9 | · | |
| Quick Ratio | 5.6 | 1.5 | 2.2 | · | |
| Interest Coverage | · | · | -27.3 | · |
Bewertung (TTM) 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-12M | $-16M | $-11M | · | |
| Market Cap | $1M | $27M | $117M | · | |
| P/E | -0.0 | -0.1 | -6.2 | · | |
| P/B | 0.1 | 9.1 | 8.9 | · | |
| P / Tangible Book | 0.1 | 9.1 | 8.9 | · | |
| P / Cash Flow | -0.1 | -1.7 | -16.3 | · | |
| Earnings Yield | -2087.8% | -1661.4% | -16.1% | · |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $3M | $2M | $1M | $859.0K | $890.8K | |
| SG&A Expense | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $362.0K | $583.0K | |
| Operating Expenses | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $5M | $3M | $2M | $1M | $1M | |
| Operating Income | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-5M | $-5M | $-3M | $-2M | $-1M | $-1M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | · | · | $221.8K | $37.1K | |
| Interest Income | $77.0K | $94.0K | $89.0K | $59.0K | $17.0K | $15.0K | $28.0K | $48.0K | $98.0K | $140.0K | $176.0K | $148.0K | $0 | $156 | |
| Other Non-op | $0 | $-2.0K | $0 | $3.0K | $151.0K | $32.0K | $-6.0K | $9.0K | $0 | $0 | · | $14.0K | · | · | |
| Net Income | $-3M | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-5M | $-5M | $-3M | $-2M | $-4M | $-2M | |
| EPS (Basic) | $-1.11 | $-0.96 | $-8.15 | $-0.06 | $-3.36 | $-5.51 | $-28.29 | $-0.25 | $-0.36 | $-0.34 | $0.61 | $-0.17 | $-1.43 | $-0.44 | |
| EPS (Diluted) | $-1.11 | $-0.96 | $-8.15 | $-0.06 | $-3.36 | $-5.51 | $-28.29 | $-0.25 | $-0.36 | $-0.34 | $0.61 | $-0.17 | $-1.43 | $-0.44 | |
| Shares (Basic) | 2,706,607 | 2,533,918 | -75,727,653 | 43,042,691 | 754,725 | 606,928 | -40,670,011 | 13,804,651 | 13,712,152 | 13,709,487 | -11,970,985 | 13,660,627 | 3,516,579 | 0 | |
| Shares (Diluted) | 2,706,607 | 2,533,918 | -75,727,653 | 43,042,691 | 754,725 | 606,928 | -40,670,011 | 13,804,651 | 13,712,152 | 13,709,487 | -11,970,985 | 13,660,627 | 3,516,579 | 0 | |
| EBITDA | $-3M | $-3M | · | $-3M | $-3M | $-3M | · | $-4M | $-5M | $-5M | · | $-2M | $-1M | · |
Bilanz 19
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $10M | $12M | $7M | $2M | $929.0K | $3M | $3M | $3M | $7M | $9M | $7M | $135.8K | $1M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $9M | · | · | |
| Prepaid Expense | $2M | $661.0K | $788.0K | $1M | $822.0K | $722.0K | $773.0K | $1M | $1M | $672.0K | $688.0K | $971.2K | · | $63.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $14.4K | $159.5K | $76.0K | |
| Current Assets | $11M | $11M | $13M | $8M | $3M | $2M | $3M | $4M | $7M | $11M | $15M | $17M | $18M | $1M | |
| Other Non-current Assets | $210.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $28.4K | $167.7K | $167.0K | |
| Total Assets | $12M | $12M | $14M | $10M | $4M | $3M | $5M | $5M | $9M | $12M | $17M | $17M | $18M | $2M | |
| Accounts Payable | $1M | $636.0K | $583.0K | $2M | $1M | $2M | $1M | $540.0K | $2M | $1M | $3M | $358.4K | $2M | $603.0K | |
| Accrued Liabilities | $1M | $2M | $2M | $561.0K | $941.0K | $1M | $508.0K | $2M | $1M | $1M | $891.0K | $355.0K | $1M | $2M | |
| Current Liabilities | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $4M | $724.0K | $3M | $7M | |
| Capital Leases | $62.0K | $70.0K | $79.0K | $87.0K | $95.0K | $102.0K | $110.0K | $117.0K | $124.0K | $131.0K | $138.0K | $144.9K | · | $0 | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $36.0K | $36.0K | · | · | $36.0K | |
| Total Liabilities | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $4M | $904.9K | $3M | $7M | |
| Common Stock | $0 | $0 | $0 | $5.0K | $3.0K | $2.0K | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $1.4K | $1.3K | $0 | |
| Paid-in Capital | $93M | $91M | $90M | $83M | $75M | $70M | $70M | $66M | $65M | $65M | $64M | $63M | $60M | $24M | |
| Retained Earnings | $-84M | $-81M | $-78M | $-75M | $-73M | $-70M | $-67M | $-64M | $-60M | $-55M | $-51M | $-47M | $-45M | $-39M | |
| Stockholders' Equity | $9M | $10M | $12M | $7M | $2M | $334.0K | $3M | $3M | $5M | $10M | $13M | $16M | $15M | $-15M | |
| Liabilities + Equity | $12M | $12M | $14M | $10M | $4M | $3M | $5M | $5M | $9M | $12M | $17M | $17M | $18M | $2M | |
| Shares Outstanding | 2,945,552 | 2,540,518 | 2,524,475 | 49,068,621 | 26,166,423 | 15,264,869 | 604,915 | 13,863,947 | 13,712,877 | 13,711,877 | 13,709,377 | 13,709,377 | 13,099,377 | 3,410,103 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $387.0K | $387.0K | $450.0K | $471.0K | $644.0K | $435.0K | $844.0K | $483.0K | $591.0K | $1M | $423.0K | $350.7K | $312.0K | $627.7K | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-4M | $-4M | $-4M | $-946.0K | $-5M | $-239.0K | $-2M | |
| Investing Cash Flow | · | · | $0 | $0 | $0 | $0 | $0 | $3M | $-6.0K | $3M | $3M | $-9M | $0 | · | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | $-13.0K | $0 | $38.0K | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Stock Issued | · | · | · | · | · | $345.0K | · | · | · | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $345.0K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $150.0K | $7M | $7M | $4M | $328.0K | $2M | $413.0K | $3.0K | $8.0K | $-13.0K | $21M | $-241.0K | · | |
| Net Change in Cash | $-716.0K | $-2M | $5M | $5M | $1M | $-2M | $-192.0K | $-459.0K | $-4M | $-1M | $2M | $7M | $-480.0K | $615.7K |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -37.7% | -31.7% | · | -36.1% | -38.7% | -43.3% | · | -31.9% | -37.0% | -74.2% | · | -27.7% | -40.6% | · | |
| ROE | -52.8% | -47.2% | · | -53.4% | -67.4% | -66.6% | · | -37.6% | -48.5% | -94.7% | · | -29.3% | -48.9% | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.9 | · | 3.6 | 1.4 | 0.6 | · | 1.6 | 2.3 | 4.4 | · | 23.0 | 5.9 | · | |
| Quick Ratio | 4.2 | 4.6 | · | 3.1 | 1.0 | 0.4 | · | 1.2 | 1.0 | 3.0 | · | 21.6 | 0.0 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -5.5 | · |
Bewertung (TTM) 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-11M | $-11M | · | $-12M | $-14M | $-16M | · | $-15M | $-16M | $-12M | · | $-9M | $-9M | · | |
| Market Cap | $12M | $15M | · | $12M | $8M | $30M | · | $53M | $67M | $71M | · | $54M | $78M | · | |
| P/E | -0.7 | -0.9 | · | -0.4 | -0.3 | -1.7 | · | -3.4 | -2.1 | -2.2 | · | -1.6 | -2.0 | · | |
| P/B | 1.3 | 1.5 | · | 1.7 | 3.7 | 90.0 | · | 19.1 | 12.6 | 7.3 | · | 3.4 | 5.2 | · | |
| P / Tangible Book | 1.3 | 1.5 | · | 1.7 | 3.7 | 90.0 | · | 19.1 | 12.6 | 7.3 | · | 3.4 | 5.2 | · | |
| P / Cash Flow | · | -8.2 | · | · | · | -15.1 | · | · | · | -16.3 | · | · | · | · | |
| Earnings Yield | -133.9% | -113.3% | · | -271.6% | -312.7% | -59.4% | · | -29.3% | -46.9% | -44.8% | · | -63.2% | -48.8% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Nettoergebnis | $-12M | $-16M | $-11M | $-8M |
| Verwässerte EPS | $-8.56 | $-29.24 | $-1.38 | $-2.22 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Liquiditätsgrad | 5.9 | 1.9 | 3.9 | — |
| Quick Ratio | 5.6 | 1.5 | 2.2 | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 20 Einreicher · $2.9M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 7 | 1 | 2 | 2 | — |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen. Änderung gegenüber Vorquartal nicht angezeigt: Die Einreicherabdeckung unterscheidet sich zwischen diesen beiden Quartalen zu stark für einen zuverlässigen Vergleich.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| KMT WEALTH MANAGEMENT, LLC | $2.035.621 | 496.493 | 71,39% | Aktien |
| VANGUARD GROUP INC | $172.624 | 421.033 | 6,05% | Aktien |
| Rothschild Wealth LLC | $109.564 | 26.723 | 3,84% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $108.933 | 26.569 | 3,82% | Aktien |
| SAPIENT CAPITAL LLC | $106.625 | 26.006 | 3,74% | Aktien |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $102.500 | 25.000 | 3,59% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $74.173 | 18.091 | 2,60% | Aktien |
| Mesirow Financial Investment Management, Inc. | $57.884 | 14.118 | 2,03% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $37.396 | 9.121 | 1,31% | Aktien |
| Lakeview Capital Partners, LLC | $30.659 | 17.420 | 1,08% | Aktien |
| Tower Research Capital LLC (TRC) | $8.134 | 1.984 | 0,29% | Aktien |
| NewEdge Advisors, LLC | $4.707 | 1.148 | 0,17% | Aktien |
| CIBC Private Wealth Group LLC | $1.214 | 5.000 | 0,04% | Aktien |
| OSAIC HOLDINGS, INC. | $820 | 200 | 0,03% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $197 | 48 | 0,01% | Aktien |
| BARCLAYS PLC | $172 | 42 | 0,01% | Aktien |
| FNY Investment Advisers, LLC | $90 | 22.000 | 0,00% | Aktien |
| MORGAN STANLEY | $82 | 20 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $25 | 6 | 0,00% | Aktien |
| UBS Group AG | $4 | 1 | 0,00% | Aktien |
Unternehmensinsider 7 Insider · 3 Führungskräfte · 5 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Lewis H Bender | President and CEO | 16. Juli 2026 A | 118.549 | 0 | 0 | $0 |
| Joseph Talamo | Chief Financial Officer | 16. Juli 2026 A | 2.239 | 0 | 0 | $0 |
| John M Wesolowski | Principal Accounting Officer | 16. Juli 2026 A | 7.102 | 0 | 0 | $0 |
| Daniel Donovan | Direktor | 16. Juli 2026 A | — | 0 | 0 | $0 |
| Emer Leahy | Direktor | 16. Juli 2026 A | — | 0 | 0 | $0 |
| Mark A Goldberg | Direktor | 16. Juli 2026 A | — | 0 | 0 | $0 |
| Thomas I H Dubin | Direktor | 16. Juli 2026 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 1 ETF
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 26.569 SH | 8. August 2026 | Täglich |